Clinical Trial Update: Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma. [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial is evaluating camrelizumab in combination with radiotherapy as neoadjuvant therapy for esophageal cancer, and the study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Esophageal Neoplasm, Immunotherapy | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING